Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26

Details for Australian Patent Application No. 2007209787 (hide)

Owner Board of Regents, The University of Texas System Dana-Farber Cancer Institute

Inventors Morimoto, Chikao; Dang, Nam H.; Schlossman, Stuart

Agent Pizzeys

Pub. Number AU-B-2007209787

Parent 2002308637

Filing date 17 August 2007

Wipo publication date 6 September 2007

Acceptance publication date 13 November 2008

International Classifications

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

Event Publications

30 August 2007 Complete Application Filed

6 September 2007 Application Open to Public Inspection

  Published as AU-B-2007209787

6 September 2007 Complete Application Filed

13 November 2008 Application Accepted

  Published as AU-B-2007209787

12 March 2009 Standard Patent Sealed

28 April 2011 Application for Amendment

  The nature of the amendment is: Amend patentee names to read Dana Farber Cancer Institute, Inc. and Board of Regents, The University of Texas System. Address for service in Australia - Pizzeys Level 2, Woden Plaza Offices Woden Town Square Woden Canberra ACT 2606

18 August 2011 Alteration of Name

  The name of the patentee has been altered to Board of Regents, The University of Texas System; Dana Farber Cancer Institute, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007209788-Cargo case

2007209786-Bill handling apparatus